XCH Biomedical Rebirth from the Outbreak of COVID-19

Since December 2019, Wuhan City, Hubei Province, China has continued to carry out influenza and related disease surveillance, and found multiple cases of viral pneumonia, all of which were diagnosed with viral pneumonia/pulmonary infection and later named COVID-19.


Subsequently, cases have appeared across the country, and at the same time, the COVID-19 outbreak has also expanded internationally. Since the outbreak, there have been a total of 219 million confirmed cases and 4.55 million deaths worldwide.


As we all know, 2020-2021 is destined to be an extraordinary year. 2021 is a difficult year, but also a year full of hope. Now as the epidemic situation is brought under control, the economies of all countries are beginning to recover. We believe that cross-border electronic trade will also become more and more prosperous.


During the COVID-19 period, Beijing Jiangsu XCH Biomedical Technology Co., Ltd. is still arranging production. At this stage, various production work is proceeding in an orderly manner. We warmly welcome partners from all over the world to expand business with us.